Company profile
Bexion Pharmaceuticals company profile
Bexion Pharmaceuticals is developing innovative cures for cancer. Unlike any other potential drug known in development, BXQ-350 has an entirely new and novel mechanism of action. Studies strongly suggest that specific tumor targeting is the result of targeting Phosphatidylserine patches that are characteristic of tumor cells and neovasculature; and that apoptosis results from activation of acid sphingomyelinase, subsequent generation of ceramide, and elevated levels of caspase.
Business identity
- Website
- http://www.bexionpharma.com
- Contact email
- [email protected]
- Phone number
- 859-757-1652
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00011-00050 employees
- Revenue range
- $1K+
- Founded
- 2006-01-01
Headquarters
- Headquarters
- Milner, Georgia, United States
- Postal code
- 41011
- Country code
- US
- Continent
- North America